# Nanopore Diagnostics, LLC — Form D

Nanopore Diagnostics, LLC of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-19. The offering totals $1.0M, of which $585K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-01-19
- Form: D
- Accession: 0001663608-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $585K
- Remaining: $415K
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2015-10-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-255439

## Issuer

- Name: Nanopore Diagnostics, LLC
- CIK: 0001663608
- Entity type: Limited Liability Company
- Jurisdiction: MISSOURI
- Incorporated: 2011
- Address: 4320 FOREST PARK AVENUE, SUITE 304, ST. LOUIS, MO, 63108
- Phone: 341-477-4334

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Christoph Bausch | Director | St. Louis, MO |
| Charles Bolten | Director | St. Louis, MO |
| Thomas Cohen | Executive Officer | St. Louis, MO |

## More

- [CIK 1663608 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1663608&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001663608-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.